InvestorsHub Logo
Followers 4
Posts 682
Boards Moderated 0
Alias Born 06/26/2013

Re: None

Thursday, 03/23/2017 3:19:59 PM

Thursday, March 23, 2017 3:19:59 PM

Post# of 30990
As I troll The internet and pick up story after story relevant to NFKB, chronic inflammation, the newly discovered biomarker GlycA for cardiac event risk, the huge Japanese study of the elderly (55 to 105), etc., they all cry out for Dr. Mullan's statement in the Rock Creek ad in the biopharmadealmakersnature publication (June 2016): "Much of the scientific excitement about this drug (anatabine) derives from the potentially far-reaching clinical relevance of its mechanism of action, implicated as it is in a wide range of inflammatory and immunological conditions".

"scientific excitement" ???? With RCPIQ at $.0012 ????
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.